By Bill Berkrot (Reuters) - Previously untreated patients experienced significant and lasting reductions in signs and symptoms of psoriatic arthritis when given Celgene Corp's experimental oral drug, apremilast, according to data from a late stage clinical trial. Patients taking either the 20 milligrams or 30 mg dose of apremilast twice a day had a statistically significant improvement in symptoms, such as painful, swollen joints, after 16 weeks of treatment compared with those who received a placebo, researchers said. ... via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment